Corteva reports third quarter and year-to-date 2022 results

Strong double-digit sales growth year-to-date raises mid-point of full-year operating ebitda 1  guidance company signs agreement to acquire biological leader symborg indianapolis , nov. 3, 2022 /prnewswire/ -- corteva, inc. (nyse: ctva) ("corteva" or the "company") today reported financial results for the third quarter and nine months ended september 30, 2022. 3q 2022 results overview net sales loss from cont.
CTVA Ratings Summary
CTVA Quant Ranking